Condition

Human Papilloma Virus (HPV) clinical trials and research

• 8Clinical trials
• 4Countries

Newest Human Papilloma Virus (HPV) clinical trials

All recruiting trials (8)

• Cantharidin and occlusion in verruca epithelium: testing a topical treatment for common warts

  This Phase 3 study tests VP-102/TO-208 (cantharidin) vs. a vehicle to see if it clears common warts in people 2 years and older who have a normal immune system.

  Recruiting at 14 sites Phase 3 Verrica Pharmaceuticals Inc. · San Diego, California and 19 other locations · NCT07637734

• DARE-HPV: testing a two-dose, two-duration approach to clear persistent hrHPV in women

  This trial tests whether DARE-HPV can clear persistent high-risk HPV in premenopausal women aged 22–50, using two doses and two treatment lengths against a placebo.

  Recruiting at 11 sites Phase 2 Daré Bioscience, Inc. · Mobile, Alabama and 10 other locations · NCT07601074

• Omitting postoperative radiation after HPV-related oropharyngeal cancer guided by ctHPVDNA monitoring

  This study tests whether some patients with HPV-related OPSCC can skip postoperative radiation after surgery if their tumors are low risk and ctHPVDNA looks negative.

  Recruiting Phase 2 Medical University of South Carolina · Charleston, South Carolina · NCT07513389

• Long-term follow-up of cantharidin (YCANTH/VP-102/TO-208) treatment for common warts

  This follow-up will try applying cantharidin (YCANTH/VP-102/TO-208) every ~21 days for up to four applications to see if it safely clears remaining common warts in people who completed earlier COVE studies.

  Recruiting at 12 sites Phase 3 Verrica Pharmaceuticals Inc. · Saint Augustine, Florida and 11 other locations · NCT07457918

• Vaginal Gel to Help HPV Clear and CIN Regress in Women with CIN1/2

  This trial tests whether a Coriolus versicolor-based vaginal gel can help HPV go away and CIN1/2 lesions improve in women aged 30–50.

  Recruiting at 2 sites University of Aarhus · Horsens and 1 other locations · NCT07429071

• Community spread of multiple infectious diseases in Cambodia from a One Health perspective

  This project will test how common and connected dengue, chikungunya, Zika, Japanese encephalitis, and West Nile infections are among people, animals, and the environment across Cambodia.

  Recruiting Institut Pasteur du Cambodge · Phnom Penh, Phnom Penh · NCT07358910

• Blood and cervical HPV DNA/RNA testing to track treatment response in cervical cancer

  This 9-month study will test two blood-based HPV tests (NavDx and Quantivirus) to see if they can track how adults with HPV-related cervical cancer respond to surgery, radiation, and chemotherapy.

  Recruiting University of Florida · Gainesville, Florida · NCT07214584

• Home screening options for cervical cancer

  This study is testing if home screening methods for cervical cancer, like using vaginal swabs and urine tests, are as effective as traditional clinic visits to help more people get screened.

  Recruiting University of Texas at Austin · El Paso, Texas · NCT06825689

Related topics

Quick answers

How many Human Papilloma Virus (HPV) clinical trials are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in United States (6 trials), Japan (2 trials), Denmark (1 trial), Cambodia (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2, Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →